Neofem Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Kalyan, Maharashtra, India, established in 2024.
2024 Kalyan, Maharashtra, India Active
Last Updated:
Access Report
About Neofem Pharmaceuticals Private Limited

Neofem Pharmaceuticals Private Limited, a active private limited company, was established on 29 October 2024 in Kalyan, Maharashtra, India. it holds CIN: U47721MH2024PTC434254. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

Its leadership includes Kunal Mandloi (Director), Abhimanyu Mahajan (Director), Jitendra Kumar Dashore (Director). It is based at C Wing-807, Emerald,, Konark Solitaire, Kdmc A, Kalyan, Maharashtra, 421102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721MH2024PTC434254

  • Registration Number

    434254

  • Incorporation Date

    29 October 2024

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 1 Year 3 Months
Company report

Neofem Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neofem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neofem Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Kunal Mandloi Director 29 Oct 2024 Current
Abhimanyu Mahajan Director 29 Oct 2024 Current
Jitendra Kumar Dashore Director 29 Oct 2024 Current
Priyank Kumar Moyade Individual Subscriber 29 Oct 2024 Current
Kapil Mahajan Individual Subscriber 29 Oct 2024 Current
Ankit Gupta Individual Subscriber 29 Oct 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neofem Pharmaceuticals.

Enhance accessibility to Neofem Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Neofem Pharmaceuticals revenue growth over time
Neofem Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neofem Pharmaceuticals?

Unlock access to Neofem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neofem Pharmaceuticals?

Unlock and access historical data on people associated with Neofem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neofem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neofem Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neofem Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Kunal Mandloi was appointed as a Director was appointed as a Director on 29 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Director Appointment

    Progress on Abhimanyu Mahajan was appointed as a Director was appointed as a Director on 29 Oct 2024 & has been associated with this company since 1 year 3 months . was documented.

  • Director Appointment

    The activity Jitendra Kumar Dashore was appointed as a Director was appointed as a Director on 29 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Director Appointment

    Priyank Kumar Moyade was appointed as a Individual Subscriber was appointed as a Individual Subscriber on 29 Oct 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Kapil Mahajan was appointed as a Individual Subscriber was appointed as a Individual Subscriber on 29 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Company Incorporation

    Progress on Neofem Pharmaceuticals Private Limited was registered on 29 Oct 2024 with Roc Mumbai & aged 1 year 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neofem Pharmaceuticals Private Limited?

The CIN of Neofem Pharmaceuticals Private Limited is U47721MH2024PTC434254.

Where is Neofem Pharmaceuticals Private Limited headquartered?

Neofem Pharmaceuticals Private Limited is headquartered at C Wing-807, Emerald,, Konark Solitaire, Kdmc A, Kalyan, Maharashtra, 421102.

When was Neofem Pharmaceuticals Private Limited incorporated?

Neofem Pharmaceuticals Private Limited was incorporated on 29 October 2024.

Who are the current directors of Neofem Pharmaceuticals Private Limited?

The current directors of Neofem Pharmaceuticals Private Limited are

Is Neofem Pharmaceuticals Private Limited a listed company?

Neofem Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Neofem Pharmaceuticals Private Limited?

The authorized capital of Neofem Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available